Henry Cai's AGIC enters US with pharma buy

The private equity fund, which focuses on investment in fast growing companies in Europe and the US, is backing a pharmaceutical group's Asian expansion.

Henry Cai's AGIC enters US with pharma buy

An AGIC Capital-led consortium has agreed to acquire Ritedose from Olympus Partners, another private equity firm.

Ritedose is a blow-fill-seal maker, a process in which plastic containers are blow-molded, filled with liquid and sealed in one continuous operation under aseptic conditions.

Founded in 1995 in South Carolina, Ritedose also develops, manufactures and sells its own generic portfolio of respiratory pharmaceutical products.

“AGIC is fully committed to providing Ritedose...

To continue reading, please login or register for free

Click for more on: henry cai | private equity | acquisitions

Print Edition

FinanceAsia Print Edition